Skip to main content

Advertisement

SpringerLink
Log in

Treatment Regimens for HIV Neurocognitive Dysfunctions in the Highly Active Antiretroviral Therapy (HAART) Era

  • Clinical Trial Report
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Liner KJ 2nd, Hall CD, Robertson KR: Effects of antiretroviral therapy on cognitive impairment. Curr HIV/AIDS Rep 2008, 5:64–71.

    Article  PubMed  Google Scholar 

  2. Antinori A, Arendt G, Becker JT, et al.: Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007, 69:1789–1799.

    Article  CAS  PubMed  Google Scholar 

  3. Cysique LA, Vaida F, Letendre S, et al.: Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology 2009, 73:342–348.

    Article  CAS  PubMed  Google Scholar 

  4. Letendre S, Marquie-Beck J, Capparelli E, et al.: Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 2008, 65:65–70.

    Article  PubMed  Google Scholar 

  5. Marra CM, Zhao Y, Clifford DB, et al.: Impact of combination anti-retroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS 2009, 23:1359–1366.

    Article  PubMed  Google Scholar 

  6. Cysique LJA, Maruff P, Brew BJ: Variable benefit in neuropsychological function in HIV infected HAART-treated patients. Neurology 2006, 66:1447–1450.

    Article  PubMed  Google Scholar 

  7. Robertson KR, Smurzynski M, Parsons TD, et al.: The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 2007, 21:1915–1921.

    Article  PubMed  Google Scholar 

  8. Schweinsburg BC, Taylor MJ, Alhassoon OM, et al.: Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors. J Neurovirol 2005, 11:356–364.

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosure

No potential conflict of interest relevant to this article was reported.

Author information

Authors and Affiliations

  1. Neurology, Microbiology/Immunology, and Neuroscience, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY, 13210, USA

    Burk Jubelt

Authors
  1. Burk Jubelt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Burk Jubelt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jubelt, B. Treatment Regimens for HIV Neurocognitive Dysfunctions in the Highly Active Antiretroviral Therapy (HAART) Era. Curr Neurol Neurosci Rep 10, 417–419 (2010). https://doi.org/10.1007/s11910-010-0141-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-010-0141-3

Keywords

Search

Navigation